학술논문

Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer
Document Type
Article
Source
In Gynecologic Oncology September 2020 158(3):631-639
Subject
Language
ISSN
0090-8258